Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Curcumin: Modulator of Key Molecular Signaling Pathways in Hormone-Independent Breast Cancer
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 14, Pages 3427
Publisher
MDPI AG
Online
2021-07-08
DOI
10.3390/cancers13143427
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Preparation, Optimization and In-Vitro Evaluation of Curcumin-Loaded Niosome@calcium Alginate Nanocarrier as a New Approach for Breast Cancer Treatment
- (2021) Iman Akbarzadeh et al. Biology-Basel
- Role of STAT3 signaling pathway in breast cancer
- (2020) Jia-hui Ma et al. Cell Communication and Signaling
- Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
- (2020) Shannon Lee et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression and clinical significance of MAPK and EGFR in triple‑negative breast cancer
- (2020) Weihua Jiang et al. Oncology Letters
- Current shreds of evidence on the anticancer role of EGCG in triple negative breast cancer: an update of the current state of knowledge
- (2020) Sabrina Bimonte et al. Infectious Agents and Cancer
- Curcumin Inhibits the Tumorigenesis of Breast Cancer by Blocking Tafazzin/Yes-Associated Protein Axis
- (2020) Yuxiu Shen et al. Cancer Management and Research
- The evolving epidemic of breast cancer in sub‐Saharan Africa: Results from the African Cancer Registry Network
- (2020) Walburga Yvonne Joko‐Fru et al. INTERNATIONAL JOURNAL OF CANCER
- The Roles of Cyclin-Dependent Kinases in Cell-Cycle Progression and Therapeutic Strategies in Human Breast Cancer
- (2020) Lei Ding et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Understanding MAPK Signaling Pathways in Apoptosis
- (2020) Jicheng Yue et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effects of curcumin complexes on MDA‑MB‑231 breast cancer cell proliferation
- (2020) Fatima Mohammed et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
- (2020) Uddalak Bharadwaj et al. PHARMACOLOGICAL REVIEWS
- Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer: A comparative, randomized, double-blind, placebo-controlled clinical trial
- (2020) Tatul Saghatelyan et al. PHYTOMEDICINE
- Signal Transduction Pathways in Breast Cancer: The Important Role of PI3K/Akt/mTOR
- (2020) Miguel A. Ortega et al. Journal of Oncology
- Curcumin inhibits the growth of triple‐negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
- (2020) Xueliang Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway
- (2020) Ahmad Tamaddoni et al. PHARMACOLOGICAL RESEARCH
- Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study
- (2020) Emily Heer et al. Lancet Global Health
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- The Canonical Wnt Pathway as a Key Regulator in Liver Development, Differentiation and Homeostatic Renewal
- (2020) Sebastian L. Wild et al. Genes
- NEDD4 Plays Roles in the Maintenance of Breast Cancer Stem Cell Characteristics
- (2020) Seon-Ae Jeon et al. Frontiers in Oncology
- Curcumin analog B14 has high bioavailability and enhances the effect of anti‐breast cancer cells in vitro and in vivo
- (2020) Hui Shen et al. CANCER SCIENCE
- Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities
- (2020) Xiufang Xu et al. Molecular Cancer
- Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells
- (2020) Yumi Fujimoto et al. Scientific Reports
- Cyclin D1 in Cancer: A Molecular Connection for Cell Cycle Control, Adhesion and Invasion in Tumor and Stroma
- (2020) Francesca Ida Montalto et al. Cells
- Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins
- (2019) Rumani Singh et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Anticancer effects of curcumin in luminal B and HER2 breast cancer cell line models
- (2019) ALEXANDRU FILIPPI et al. Romanian Biotechnological Letters
- STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
- (2019) Jiang-Jiang Qin et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Association of p53 expression with poor prognosis in patients with triple-negative breast invasive ductal carcinoma
- (2019) Jing-ping Li et al. MEDICINE
- Ilamycin C induces apoptosis and inhibits migration and invasion in triple-negative breast cancer by suppressing IL-6/STAT3 pathway
- (2019) Qing Xie et al. Journal of Hematology & Oncology
- Antitumor effects of saikosaponin b2 on breast cancer cell proliferation and migration
- (2019) Qing Ma et al. Molecular Medicine Reports
- Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
- (2019) Weixiao An et al. Frontiers in Pharmacology
- TP53 Mutations Promote Immunogenic Activity in Breast Cancer
- (2019) Zhixian Liu et al. Journal of Oncology
- Effects of Somatostatin, Curcumin and Quercetin on the fatty acid profile of breast cancer cell membranes
- (2019) Aysegul Hanikoglu et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling
- (2019) Shaojie Jiang et al. Cell Communication and Signaling
- PI3K/AKT/mTOR pathway inhibitors in triple-negative breast cancer: a review on drug discovery and future challenges
- (2019) Mohammad A. Khan et al. DRUG DISCOVERY TODAY
- Curcumin induces DNA damage by mediating homologous recombination mechanism in triple negative breast cancer
- (2019) Gamze Guney Eskiler et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Curcumin derivative WZ35 inhibits tumor cell growth via ROS-YAP-JNK signaling pathway in breast cancer
- (2019) Lihua Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine
- (2019) Hua Luo et al. Chinese Medicine
- Natural products targeting the PI3K-Akt-mTOR signaling pathway in cancer: A novel therapeutic strategy
- (2019) Devesh Tewari et al. SEMINARS IN CANCER BIOLOGY
- Curcumin stabilizes p53 by interaction with NAD(P)H:quinone oxidoreductase 1 in tumor-derived cell lines
- (2019) Carlos César Patiño-Morales et al. Redox Biology
- Folic Acid-Functionalized, Condensed Magnetic Nanoparticles for Targeted Delivery of Doxorubicin to Tumor Cancer Cells Overexpressing the Folate Receptor
- (2019) Athina Angelopoulou et al. ACS Omega
- Curcumin inhibits autocrine growth hormone-mediated invasion and metastasis by targeting NF-κB signaling and polyamine metabolism in breast cancer cells
- (2018) Ajda Coker-Gurkan et al. AMINO ACIDS
- Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells
- (2018) Xiaoting Li et al. ANTI-CANCER DRUGS
- The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53
- (2018) Anna Budina-Kolomets et al. CANCER BIOLOGY & THERAPY
- JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance
- (2018) Tianyi Wang et al. Cell Metabolism
- Curcumin as an Adjunct Therapy and microRNA Modulator in Breast Cancer
- (2018) Saeed Norouzi et al. CURRENT PHARMACEUTICAL DESIGN
- STAT3 and apoptosis challenges in cancer
- (2018) Nazanin Fathi et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Apoptosis: A Target for Anticancer Therapy
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin
- (2018) Touko Inao et al. Oncotarget
- Targeting the cell cycle in breast cancer: towards the next phase
- (2018) KL Thu et al. CELL CYCLE
- Curcumin and paclitaxel induce cell death in breast cancer cell lines
- (2018) Gloria Calaf et al. ONCOLOGY REPORTS
- Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells
- (2018) Jaemoo Chun et al. PHYTOTHERAPY RESEARCH
- Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells
- (2018) SHENGLING FU et al. ANTICANCER RESEARCH
- The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
- (2018) Ali Masjedi et al. BIOMEDICINE & PHARMACOTHERAPY
- PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells
- (2018) Ao Yao et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Molecular targets of curcumin in breast cancer (Review)
- (2018) Xinqiang Song et al. Molecular Medicine Reports
- Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT
- (2018) Chenxia Hu et al. PHYTOMEDICINE
- Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
- (2018) Yen-Dun Tony Tzeng et al. Frontiers in Pharmacology
- Roles of Wnt Target Genes in the Journey of Cancer Stem Cells
- (2017) Jee-Heun Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Curcumin: the spicy modulator of breast carcinogenesis
- (2017) Urmila Banik et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- TGF‑β signaling: A complex role in tumorigenesis (Review)
- (2017) Shuang Liu et al. Molecular Medicine Reports
- NF-κB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers
- (2017) Paola Poma et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- AXL is a marker for epithelial‑mesenchymal transition in esophageal squamous cell carcinoma
- (2017) Guoan Zhang et al. Oncology Letters
- Caspase-3 over-expression is associated with poor overall survival and clinicopathological parameters in breast cancer: a meta-analysis of 3091 cases
- (2017) Xia Yang et al. Oncotarget
- Wnt signaling in triple-negative breast cancer
- (2017) SÖ-G Pohl et al. Oncogenesis
- Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy
- (2017) Wenda Zhang et al. Scientific Reports
- Ki67, PCNA, and MCM proteins: Markers of proliferation in the diagnosis of breast cancer
- (2016) Miroslava Juríková et al. ACTA HISTOCHEMICA
- Renewed interest in the progesterone receptor in breast cancer
- (2016) Elgene Lim et al. BRITISH JOURNAL OF CANCER
- Molecular mechanisms for tumour resistance to chemotherapy
- (2016) Shu-Ting Pan et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Mitochondrial Stat3, the Need for Design Thinking
- (2016) Rui Yang et al. International Journal of Biological Sciences
- Effect of curcumin and paclitaxel on breast carcinogenesis
- (2016) Edgar Teddy Quispe-Soto et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Curcumin inhibits invasive capabilities through epithelial mesenchymal transition in breast cancer cell lines
- (2016) Marcela Gallardo et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Curcumin inhibits intracellular fatty acid synthase and induces apoptosis in human breast cancer MDA-MB-231 cells
- (2016) HUIJIN FAN et al. ONCOLOGY REPORTS
- Triple negative breast cancer: shedding light onto the role of pi3k/akt/mtor pathway
- (2016) Daniela Massihnia et al. Oncotarget
- Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death
- (2016) Kai Wang et al. Scientific Reports
- The relationship between nuclear factor (NF)-κB family gene expression and prognosis in triple-negative breast cancer (TNBC) patients receiving adjuvant doxorubicin treatment
- (2016) Ji-Yeon Kim et al. Scientific Reports
- Association between Mutation and Expression of TP53 as a Potential Prognostic Marker of Triple-Negative Breast Cancer
- (2016) Ji-Yeon Kim et al. Cancer Research and Treatment
- Lead Phytochemicals for Anticancer Drug Development
- (2016) Sukhdev Singh et al. Frontiers in Plant Science
- Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes
- (2016) Xiaofeng Dai et al. Journal of Cancer
- Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
- (2016) Mi Park et al. Cells
- Curcumin Suppresses Proliferation and Migration of MDA-MB-231 Breast Cancer Cells through Autophagy-Dependent Akt Degradation
- (2016) Feng Guan et al. PLoS One
- Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
- (2015) Naoko Honma et al. BMC CANCER
- DNA damage checkpoint recovery and cancer development
- (2015) Haiyong Wang et al. EXPERIMENTAL CELL RESEARCH
- The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications
- (2015) Marcello Maugeri-Saccà et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Endocrine therapy resistance in breast cancer: current status, possible mechanisms and overcoming strategies
- (2015) Weimin Fan et al. Future Medicinal Chemistry
- Targeting Apoptosis and Multiple Signaling Pathways with Icariside II in Cancer Cells
- (2015) Muhammad Khan et al. International Journal of Biological Sciences
- Modulator of Apoptosis 1 (MOAP-1) Is a Tumor Suppressor Protein Linked to the RASSF1A Protein
- (2015) Jennifer Law et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PTEN and NEDD4 in Human Breast Carcinoma
- (2015) Yilun Chen et al. PATHOLOGY & ONCOLOGY RESEARCH
- Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group
- (2015) Samantha C. Sodergren et al. Targeted Oncology
- RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
- (2015) Paola Indovina et al. Oncotarget
- Dissecting the Role of Curcumin in Tumour Growth and Angiogenesis in Mouse Model of Human Breast Cancer
- (2015) Sabrina Bimonte et al. Biomed Research International
- Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion
- (2015) Nelson Yee Cancers
- β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
- (2015) Jinhua Xu et al. PLoS One
- Analysis of PIK3CA Mutations and Activation Pathways in Triple Negative Breast Cancer
- (2015) Paolo Cossu-Rocca et al. PLoS One
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- Structural insights into the transcription-independent apoptotic pathway of p53
- (2014) Seung-Wook Chi BMB Reports
- Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
- (2014) Padmamalini Thulasiraman et al. BMC CANCER
- The MAPK pathway across different malignancies: A new perspective
- (2014) Mauricio Burotto et al. CANCER
- The differential susceptibilities of MCF-7 and MDA-MB-231 cells to the cytotoxic effects of curcumin are associated with the PI3K/Akt-SKP2-Cip/Kips pathway
- (2014) Tao Jia et al. Cancer Cell International
- Role of MAPK in oncolytic herpes viral therapy in triple-negative breast cancer
- (2014) S Gholami et al. CANCER GENE THERAPY
- Triple Negative Breast Cancer - BCL2 in Prognosis and Prediction. Review
- (2014) Katerina Bouchalova et al. CURRENT DRUG TARGETS
- Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
- (2014) Wei Wang et al. CURRENT MEDICINAL CHEMISTRY
- The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease
- (2014) X. Varelas DEVELOPMENT
- The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer
- (2014) SHU-WEI WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Transcriptional Roles of PARP1 in Cancer
- (2014) Matthew J. Schiewer et al. MOLECULAR CANCER RESEARCH
- miR181b is induced by the chemopreventive polyphenol curcumin and inhibits breast cancer metastasis via down-regulation of the inflammatory cytokines CXCL1 and -2
- (2014) Emanuel Kronski et al. Molecular Oncology
- Potassium channels in cell cycle and cell proliferation
- (2014) D. Urrego et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Ion channels and apoptosis in cancer
- (2014) C. D. Bortner et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- KIF14 Promotes AKT Phosphorylation and Contributes to Chemoresistance in Triple-Negative Breast Cancer
- (2014) Stina M. Singel et al. NEOPLASIA
- Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings
- (2013) T. M. A. Abdel-Fatah et al. ANNALS OF ONCOLOGY
- Curcumin Inhibits TGF-β1-Induced MMP-9 and Invasion through ERK and Smad Signaling in Breast Cancer MDA-MB-231 Cells
- (2013) Na Mo et al. Asian Pacific Journal of Cancer Prevention
- Wnt signaling in triple negative breast cancer is associated with metastasis
- (2013) Nandini Dey et al. BMC CANCER
- p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents
- (2013) Xinbing Sui et al. CANCER LETTERS
- p34 is a novel regulator of the oncogenic behavior of NEDD4-1 and PTEN
- (2013) S-W Hong et al. CELL DEATH AND DIFFERENTIATION
- Review of Poly (ADP-ribose) Polymerase (PARP) Mechanisms of Action and Rationale for Targeting in Cancer and Other Diseases
- (2013) Julio Morales et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Gain-of-function mutant p53-R280K mediates survival of breast cancer cells
- (2013) Yun-Hee Bae et al. Genes & Genomics
- Novel prognostic markers for patients with triple-negative breast cancer
- (2013) Ling Zhou et al. HUMAN PATHOLOGY
- Curcumin Suppresses Doxorubicin-Induced Epithelial–Mesenchymal Transition via the Inhibition of TGF-β and PI3K/AKT Signaling Pathways in Triple-Negative Breast Cancer Cells
- (2013) Wei-Chih Chen et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Mitochondrial Localized Stat3 Promotes Breast Cancer Growth via Phosphorylation of Serine 727
- (2013) Qifang Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Effect of Curcumin on Breast Cancer Cells
- (2013) Dongwu Liu et al. Journal of Breast Cancer
- Mutant p53-Notch1 Signaling Axis Is Involved in Curcumin-Induced Apoptosis of Breast Cancer Cells
- (2013) Yun-Hee Bae et al. KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
- Curcumin enhances TRAIL-induced apoptosis of breast cancer cells by regulating apoptosis-related proteins
- (2013) Sojung Park et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a
- (2013) Jiaoli Guo et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Distinct roles of STAT3 and STAT5 in the pathogenesis and targeted therapy of breast cancer
- (2013) Sarah R. Walker et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- STAT signaling in different breast cancer sub-types
- (2013) Priscilla A. Furth MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Canonical and non-canonical NF-κB signaling promotes breast cancer tumor-initiating cells
- (2013) M F Kendellen et al. ONCOGENE
- Expression and activation of P38 MAP kinase in invasive ductal breast cancers: Correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins
- (2013) JEAN-LOUIS MERLIN et al. ONCOLOGY REPORTS
- Structural determinants of DISC function: New insights into death receptor-mediated apoptosis signalling
- (2013) Tamas Sessler et al. PHARMACOLOGY & THERAPEUTICS
- Differential Activation of Wnt-β-Catenin Pathway in Triple Negative Breast Cancer Increases MMP7 in a PTEN Dependent Manner
- (2013) Nandini Dey et al. PLoS One
- Persistent Current Blockers of Voltage-Gated Sodium Channels: A Clinical Opportunity for Controlling Metastatic Disease
- (2013) Mustafa B.A. Djamgoz et al. Recent Patents on Anti-Cancer Drug Discovery
- Mechanistic evaluation of the signaling events regulating curcumin-mediated chemosensitization of breast cancer cells to 5-fluorouracil
- (2013) B S Vinod et al. Cell Death & Disease
- Role of STAT3 in Cancer Metastasis and Translational Advances
- (2013) Mohammad Zahid Kamran et al. Biomed Research International
- Curcumin improves the therapeutic efficacy of Listeriaat-Mage-b vaccine in correlation with improved T-cell responses in blood of a triple-negative breast cancer model 4T1
- (2013) Manisha Singh et al. Cancer Medicine
- Proteomic Identification of a Direct Role for Cyclin D1 in DNA Damage Repair
- (2012) S. Jirawatnotai et al. CANCER RESEARCH
- HER2-Associated Radioresistance of Breast Cancer Stem Cells Isolated from HER2-Negative Breast Cancer Cells
- (2012) N. Duru et al. CLINICAL CANCER RESEARCH
- Chemopreventive and Chemotherapeutic Potential of Curcumin in Breast Cancer
- (2012) Dona Sinha et al. CURRENT DRUG TARGETS
- Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin
- (2012) Shih-Han Sun et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy
- (2012) Libero Santarpia et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer
- (2012) Yaser R. Hussein et al. HUMAN PATHOLOGY
- MicroRNA-181b regulates NF-κB–mediated vascular inflammation
- (2012) Xinghui Sun et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of Wnt3 Activates Wnt/ -Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells
- (2012) Y. Wu et al. MOLECULAR CANCER RESEARCH
- Curcumin enhances the anticancer effects of trichostatin a in breast cancer cells
- (2012) Guang Yan et al. MOLECULAR CARCINOGENESIS
- Curcumin induces apoptosis of triple-negative breast cancer cells by inhibition of EGFR expression
- (2012) XIAO-DONG SUN et al. Molecular Medicine Reports
- Reactivation of RASSF1A in Breast Cancer Cells by Curcumin
- (2012) Liping Du et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- TGF-β autocrine pathway and MAPK signaling promote cell invasiveness and in vivo mammary adenocarcinoma tumor progression
- (2012) MARÍA CECILIA DAROQUI et al. ONCOLOGY REPORTS
- Curcumin inhibits LPS-induced EMT through downregulation of NF-κB-Snail signaling in breast cancer cells
- (2012) TAO HUANG et al. ONCOLOGY REPORTS
- Activation Status of Wnt/ß-Catenin Signaling in Normal and Neoplastic Breast Tissues: Relationship to HER2/neu Expression in Human and Mouse
- (2012) Sara Khalil et al. PLoS One
- Wnt Pathway Regulation of Embryonic Stem Cell Self-Renewal
- (2012) B. J. Merrill Cold Spring Harbor Perspectives in Biology
- MAP Kinase Pathways
- (2012) D. K. Morrison Cold Spring Harbor Perspectives in Biology
- Modulating the vascular behavior of metastatic breast cancer cells by curcumin treatment
- (2012) Anna L. Palange et al. Frontiers in Oncology
- Nucleolar NF-κB/RelA mediates apoptosis by causing cytoplasmic relocalization of nucleophosmin
- (2011) N Khandelwal et al. CELL DEATH AND DIFFERENTIATION
- Enhanced Metastasis Suppression by Targeting TRAIL Receptor 2 in a Murine Model of Triple-Negative Breast Cancer
- (2011) D. Malin et al. CLINICAL CANCER RESEARCH
- The Potential Utility of Curcumin in the Treatment of HER-2-Overexpressed Breast Cancer: AnIn VitroandIn VivoComparison Study with Herceptin
- (2011) Hung-Wen Lai et al. Evidence-based Complementary and Alternative Medicine
- The curcumin analogue hydrazinocurcumin exhibits potent suppressive activity on carcinogenicity of breast cancer cells via STAT3 inhibition
- (2011) XIAOFEI WANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
- (2011) Lauren L.C. Marotta et al. JOURNAL OF CLINICAL INVESTIGATION
- Apoptosis in cancer: from pathogenesis to treatment
- (2011) Rebecca SY Wong JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Oct4 was a novel target of Wnt signaling pathway
- (2011) Jun Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
- (2011) Siwanon Jirawatnotai et al. NATURE
- Oncogenic Role of the E3 Ubiquitin Ligase NEDD4-1, a PTEN Negative Regulator, in Non-Small-Cell Lung Carcinomas
- (2010) Nicola Amodio et al. AMERICAN JOURNAL OF PATHOLOGY
- Wnt signalling and the control of cellular metabolism
- (2010) Jaswinder K. Sethi et al. BIOCHEMICAL JOURNAL
- The phosphatidyl inositol 3-kinase/AKT signaling pathway in breast cancer
- (2010) Carlos A. Castaneda et al. CANCER AND METASTASIS REVIEWS
- Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
- (2010) Mathilde Bayet-Robert et al. CANCER BIOLOGY & THERAPY
- Novel STAT3 Phosphorylation Inhibitors Exhibit Potent Growth-Suppressive Activity in Pancreatic and Breast Cancer Cells
- (2010) L. Lin et al. CANCER RESEARCH
- Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells
- (2010) Wen-Feng Hua et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Vimentin is a novel AKT1 target mediating motility and invasion
- (2010) Q-S Zhu et al. ONCOGENE
- New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells
- (2009) Li Lin et al. CANCER SCIENCE
- Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/β-catenin signaling
- (2009) Chandra P. Prasad et al. CHEMICO-BIOLOGICAL INTERACTIONS
- The Biological Functions of NF-κB1 (p ) and its Potential as an Anti-Cancer Target
- (2009) Yonghui Yu et al. CURRENT CANCER DRUG TARGETS
- ERK and cell death: Mechanisms of ERK-induced cell death - apoptosis, autophagy and senescence
- (2009) Sebastien Cagnol et al. FEBS Journal
- Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-κBp65 expression in breast cancer MDA-MB-231 cells
- (2009) Su INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- TGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
- (2009) Shinako Araki et al. JOURNAL OF CLINICAL INVESTIGATION
- Curcumin reduces the expression of Bcl-2 by upregulating miR-15a and miR-16 in MCF-7 cells
- (2009) Jie Yang et al. MEDICAL ONCOLOGY
- Curcumin and its analogues: Potential anticancer agents
- (2009) Dinesh Kumar Agrawal et al. MEDICINAL RESEARCH REVIEWS
- Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFκB, cyclinD and MMP-1 transcription
- (2009) Q. Liu et al. PHYTOMEDICINE
- CDK Inhibitors: Cell Cycle Regulators and Beyond
- (2008) Arnaud Besson et al. DEVELOPMENTAL CELL
- TRAIL Resistance of Breast Cancer Cells Is Associated with Constitutive Endocytosis of Death Receptors 4 and 5
- (2008) Y. Zhang et al. MOLECULAR CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started